Zobrazeno 1 - 10
of 105
pro vyhledávání: '"disease-modifying osteoarthritis drugs"'
Autor:
O. A. Shavlovskaya
Publikováno v:
Фармакоэкономика, Vol 16, Iss 4, Pp 700-707 (2024)
The data on the classification of drugs, which are prescribed for the treatment of patients with joint and spine diseases, such as osteoarthritis (OA) and rheumatoid arthritis (RA), are presented. The groups of drugs widely used in clinical practice
Externí odkaz:
https://doaj.org/article/83e2753bff4a43a6810cf3f61be59894
Autor:
O. A. Shavlovskaya, О. А. Gromova, A. Yu. Kochish, Yu. D. Yukhnovskaya, I. D. Romanov, I. A. Bokova
Publikováno v:
Фармакоэкономика, Vol 16, Iss 3, Pp 482-499 (2023)
The review examines pharmacological agents that can have potential disease-modifying osteoarthritis drugs (DMOADs) status. DMOADs prevent the progression and further structural joint damage (structure-modifying effect), leading to a decrease in sympt
Externí odkaz:
https://doaj.org/article/25c7496b78894062b3703d4595d8f68f
Publikováno v:
Фармакоэкономика, Vol 16, Iss 2, Pp 317-330 (2023)
Osteoarthritis (OA) is a painful and disabling disease that affects millions of people around the world. OA is the most common form of arthritis and is characterized by joint pain and stiffness, leading to a decrease in functional activity and loss o
Externí odkaz:
https://doaj.org/article/5223f48a9a0d4362a2cbcad923476af1
Autor:
Gyeong Min Kim, Doo Ri Park, Thi Thu Ha Nguyen, Jiseon Kim, Jihee Kim, Myung-Ho Sohn, Won-Kyu Lee, Soo Young Lee, Hyunbo Shim
Publikováno v:
Biomedicines, Vol 11, Iss 10, p 2844 (2023)
Osteoarthritis (OA) is the most common joint disease that causes local inflammation and pain, significantly reducing the quality of life and normal social activities of patients. Currently, there are no disease-modifying OA drugs (DMOADs) available,
Externí odkaz:
https://doaj.org/article/5b2e284499bd4a42b5680439ca38020a
Sprifermin: Effects on Cartilage Homeostasis and Therapeutic Prospects in Cartilage-Related Diseases
Autor:
Zongmian Song, Yusheng Li, Chunfeng Shang, Guowei Shang, Hongwei Kou, Jinfeng Li, Songfeng Chen, Hongjian Liu
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
When suffering from osteoarthritis (OA), articular cartilage homeostasis is out of balance and the living quality declines. The treatment of knee OA has always been an unsolved problem in the world. At present, symptomatic treatment is mainly adopted
Externí odkaz:
https://doaj.org/article/e1d6842aa412475398b636f0755ea266
Autor:
Yuchen He, Zhong Li, Peter G. Alexander, Brian D. Ocasio-Nieves, Lauren Yocum, Hang Lin, Rocky S. Tuan
Publikováno v:
Biology, Vol 9, Iss 8, p 194 (2020)
As the most common chronic degenerative joint disease, osteoarthritis (OA) is the leading cause of pain and physical disability, affecting millions of people worldwide. Mainly characterized by articular cartilage degradation, osteophyte formation, su
Externí odkaz:
https://doaj.org/article/608cd20e10984a1c9aa9dd79bfbee99c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Heungdeok Kim, Jinwon Seo, Yunsin Lee, Kiwon Park, Thomas A. Perry, Nigel K. Arden, Ali Mobasheri, Heonsik Choi
In this narrative review article, we critically assess the current state of the osteoarthritis (OA) drug development pipeline. We discuss the current state-of-the-art in relation to the development and evaluation of candidate disease-modifying OA dru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92bc365529738d9d6cea09ea90b0f0d4
http://urn.fi/urn:nbn:fi-fe2023042839332
http://urn.fi/urn:nbn:fi-fe2023042839332
